Aiforia Technologies Oyj (HEL:AIFORIA)

Market Cap	35.84M -56.9%
Revenue (ttm)	2.89M +0.6%
Net Income	-13.74M
EPS	-0.42
Shares Out	37.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,354
Open	0.9750
Previous Close	0.9230
Day's Range	0.9580 - 1.0300
52-Week Range	0.8500 - 3.0900
Beta	0.12
Analysts	Sell
Price Target	1.05 (+9.6%)
Est. Earnings	Nov 27, 2026

About Aiforia Technologies Oyj

Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 67
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: AIFORIA

Financial Performance

In 2025, Aiforia Technologies Oyj's revenue was 3.54 million, an increase of 23.95% compared to the previous year's 2.85 million. Losses were -12.67 million, 6.01% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for AIFORIA stock is "Sell." The 12-month stock price target is €1.05, which is an increase of 9.60% from the latest price.

Price Target

€1.05

(9.60% upside)

Analyst Consensus: Sell

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 9, 2026

Data Sources Report a data error